Carelide employees accompanied by François Ruffin during their demonstration on January 13, 2023. DENIS CHARLET / AFP
An immediate contribution of 5 million euros is planned to enable at least 300 employees to keep their jobs.
The French pharmaceutical companies Delpharm and Aguettant will get the infusion bag manufacturer Carelide out of the rut, with the support of the State. This company from Mouvaux (Nord) had been placed in receivership on October 24 against “a cash crunch”. Resulting from a sale in 2019 of Macopharma, Carelide employs 400 people, for some 39 million euros in turnover. On Friday, the Lille-Métropole commercial court authorized the transfer to the two laboratories.
Following an intense political mobilization, the project to take over Aguettant and Delpharm was presented in extremis in mid-January, in the absence of any other candidate. “The offer is likely to allow the sustainability of the companynoted the court on Friday. She is socially satisfying. » The project provides for only nine job cuts, according to union delegates. “It is the culmination of two months of hard work to save 400 jobs and an industry essential for the health of the French”welcomed the Minister of Industry, Roland Lescure.
Carelide is one of three companies producing infusion bags in Europe. It mainly supplies hospitals. The State participates in its rescue. “The buyers’ project provides for more than 40 million euros of investment and that is why we are supporting it, with 20 million loans and 5 million grants”, detailed the Minister. The Hauts-de-France region and the European Metropolis of Lille also announced on Friday that they would submit to the vote a subsidy of 1 million euros each to safeguard this “strategic business”. “We have a French industrialist who manufactures bags in France with investments in France, now it’s up to hospitals to buy our bags”reacted the CFDT delegate.
TO HAVE ALSO – Danone: Agnès Pannier-Runacher calls forrelocation“, after the appointment of the new Managing Director